Lv72
5000 积分 2021-08-30 加入
The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
1个月前
已关闭
Extraosseous Plasmacytoma Confers Poor Outcomes in Primary Plasma Cell Leukemia
1个月前
已完结
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies
1个月前
已完结
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia in Japan
1个月前
已完结
European Myeloma Network Consensus Statement on Functional High‐Risk Multiple Myeloma
1个月前
已完结
Efficacy and safety of anti-CD38 monoclonal antibodies in patients with newly diagnosed multiple myeloma: an updated systematic review and meta-analysis based on randomized controlled trials
3个月前
已关闭
Efficacy and safety of anti-CD38 monoclonal antibodies in patients with newly diagnosed multiple myeloma: an updated systematic review and meta-analysis based on randomized controlled trials
3个月前
已完结
皖公网安备34019202002308
